University of Saskatchewan
Also known as: College of Pharmacy & Nutrition, University of Saskatchewan | Department of Anesthesia, University of Saskatchewan, Canada | Department of Anesthesiology, Perioperative Medicine and Pain Management, University of Saskatchewan | Department of Anesthesiology, University of Saskatchewan | Department of Medicine University of Saskatchewan | Dept OB/GYN, University of Saskatchewan | Don Cockcroft | Dr.Hani Jawa | Dr.Jennifer Jones | Dr.Wael El-matary | Jim Pattison Children's Hospital Foundation | Mela, Mansfield, M.D. | Royal University Hospital, Saskatoon, Saskatchewan | Royal University Hospital, Saskatoon, Saskatchewan, Canada | Saskatchewan Cancer Agency | Saskatoon Cancer Center | School Of Rehabilitation Science, University Of Saskatchewan | University of Saskatchewan | University of Saskatchewan College of Medicine | University of Saskatchewan, Department of Anesthesia | University of Saskatchewan, Department of Anesthesiology, Perioperative Medicine, and Pain Management | University of Saskatchewan, Department of Medicine, Division of Cardiology | University of Saskatchewan, Department of Medicine, Division of Hematology | University of Saskatchewan, Department of Medicine, Division of Respirology, Critical Care and Sleep Medicine | University of Saskatchewan, Department of Pediatrics, Head of Neonatal Research Group | University of Saskatchewan, Dept. of Obstetrics and Gynecology | University of Saskatchewan, Dept. of Obstetrics and Gynecology, College of Medicine | University of Saskatchewan, Saskatoon, SK,Canada | University of Saskatchew Full Professor | U of S Department of Anesthesiology, Perioperative Medicine and Pain Management
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1995Last known activity
Nov 30, 2025
Timeline
1900s
- Jan 1, 1907
University of Saskatchewan— Founded
Drugs by trial phase (121 distinct, 118 trials)
Phase 4 (42 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (22 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Other trials (30 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Adenocarcinoma
- Angina, Unstable
- Anorexia
- Anorexia Nervosa
- Arsenic Poisoning
- Asthma
- Bipolar Disorder
- Brain Diseases
- Carcinoma, Non-Small-Cell Lung
- Cardiovascular Diseases
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Coronary Artery Disease
- Crohn Disease
- Delirium
- Dementia
- Depression
- Depressive Disorder
- Depressive Disorder, Treatment-Resistant
- Diabetic Nephropathies
- Drug-Related Side Effects and Adverse Reactions
- Emergencies
- Epilepsy
- Esophageal Neoplasms
- Fetal Macrosomia
- Fractures, Bone
- Hemorrhage
- Hip Fractures
- Hypersensitivity
- Hypertension
- Hypertension, Pulmonary
- Hypoglycemia
- Infant, Newborn, Diseases
- Infertility
- Inflammation
- Influenza, Human
- Labor Pain
- Lung Neoplasms
- Major Depressive Disorder
- Menorrhagia
- Metabolic Syndrome
- Muscle Weakness
- Osteoporosis
- Pathologic Processes
- Persistent Fetal Circulation Syndrome
- Pneumonia
- Pneumonia, Aspiration
- Poisoning
- Postoperative Complications
- Postoperative Hemorrhage
- Postoperative Pain
- Postpartum Hemorrhage
- Pregnancy, Ectopic
- Pregnancy in Diabetics
- Prostatic Neoplasms
- Pulmonary Valve Insufficiency
- Respiratory Aspiration
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Hypersensitivity
- Respiratory Insufficiency
- Sarcopenia
- Sleep Apnea, Obstructive
- Sleep Apnea Syndromes
- Syndrome
- Tissue Adhesions
- Ulcer
- Uterine Inertia
Recent trials (50)
- NCT07178678Sponsor investigatorPhase 2Nov 30, 2025
- NCT07178678Lead sponsorPhase 2Nov 30, 2025
- NCT06899724OfficialN/AJun 1, 2025
- NCT06955715Lead sponsorN/AApr 15, 2025
- NCT06955715Sponsor investigatorN/AApr 15, 2025
- NCT06955715OfficialN/AApr 15, 2025
- NCT06900569Sponsor investigatorN/AMar 22, 2025
- NCT06900569Lead sponsorN/AMar 22, 2025
- NCT06641245CollaboratorN/AJan 31, 2025
- NCT06641245OfficialN/AJan 31, 2025
- NCT06574100Sponsor investigatorPhase 1Sep 30, 2024
- NCT06574100Lead sponsorPhase 1Sep 30, 2024
- NCT06574100OfficialPhase 1Sep 30, 2024
- NCT06433453Lead sponsorPhase 4Apr 22, 2024
- NCT06433453Sponsor investigatorPhase 4Apr 22, 2024
Details
- Founded
- Saskatoon, CA Jan 1, 1907
- Last known activity
- Nov 30, 2025